These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37874097)

  • 1. Preferences about Future Alzheimer's Disease Treatments Elicited through an Online Survey Using the Threshold Technique.
    Roldan Munoz S; de Vries ST; Lankester G; Pignatti F; van Munster BC; Radford I; Guizzaro L; Mol PGM; Hillege H; Postmus D
    J Prev Alzheimers Dis; 2023; 10(4):756-764. PubMed ID: 37874097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
    Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
    J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making.
    Mansfield C; Bullok K; Fuhs JV; Tockhorn-Heidenreich A; Andrews JS; DiBenedetti D; Matthews BR; Darling JC; Sutphin J; Hauber B
    Patient; 2022 Sep; 15(5):551-564. PubMed ID: 35435572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why would caregivers not want to treat their relative's Alzheimer's disease?
    Karlawish JH; Casarett DJ; James BD; Tenhave T; Clark CM; Asch DA
    J Am Geriatr Soc; 2003 Oct; 51(10):1391-7. PubMed ID: 14511158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
    Johnson FR; Ozdemir S; Mansfield C; Hass S; Miller DW; Siegel CA; Sands BE
    Gastroenterology; 2007 Sep; 133(3):769-79. PubMed ID: 17628557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's willingness to accept perceived risks for vasomotor symptom relief.
    Johnson FR; Ozdemir S; Hauber B; Kauf TL
    J Womens Health (Larchmt); 2007 Sep; 16(7):1028-40. PubMed ID: 17903080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Sharpley AL
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
    Postmus D; Richard S; Bere N; van Valkenhoef G; Galinsky J; Low E; Moulon I; Mavris M; Salmonsson T; Flores B; Hillege H; Pignatti F
    Oncologist; 2018 Jan; 23(1):44-51. PubMed ID: 29079638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
    Johnson FR; Hauber AB; Ozdemir S; Lynd L
    Value Health; 2010; 13(4):418-23. PubMed ID: 20230550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions.
    Montano-Campos JF; Gonzalez JM; Rickert T; Fairchild AO; Levitan B; Reed SD
    MDM Policy Pract; 2023; 8(1):23814683221148715. PubMed ID: 36654678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies.
    Fairchild AO; Reed SD; Gonzalez JM
    Med Decis Making; 2023 Feb; 43(2):227-238. PubMed ID: 36326189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.